New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
12:38 EDTACLS, LRCXAxcelis sells assets to Lam Research for $10.72M
Axcelis Technologies disclosed that it (ACLS) and Lam Research (LRCX) entered into and consummated an asset purchase agreement pursuant to which Axcelis sold and Lam purchased certain intellectual property rights, a dry strip processing system and other assets relating to the company’s dry strip systems business in exchange for a cash payment of up to $10.72M. The purchased intellectual property rights include, among other things, worldwide patent rights, patent applications, copyrights, industrial designs, know-how and related rights used by the company in its dry strip business. Under the terms, $2M of the purchase price is deferred and payable in installments upon, and subject to, the completion of certain transition milestones over various dates through June 30, 2014.
News For ACLS;LRCX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
11:55 EDTACLSVertex says 'dismayed' by Axcelis letter to shareholders
Vertex Capital Advisors, owner of 6.7% of the outstanding common stock of Axcelis, issued a statement, which read in part, "We were dismayed to read the February 13, 2015 Axcelis letter to stockholders; a letter we believe to be a fanciful communication whose central purpose appears to be an effort to obscure and divert attention from the longstanding reality at the Company: Axcelis has a storied history of poor operating performance, poor corporate governance, and miserable stockholder returns. It was not until the Company was faced with outside stockholder pressure from Vertex at last year's annual meeting of stockholders that the Company's Board of Directors seemed prodded into action. Many of the 'bold' actions the Axcelis Board touts in its letter to stockholders, appear to have been undertaken in reaction to our involvement and suggestions we made to the Company to create stockholder value...We strongly believe in the Company's potential and, because of that, have over $20 million invested in the Company. But in light of its poor historical track record, which extends over a decade now, we simply do not have confidence in the current Board's ability to properly oversee management and protect the interests of stockholders...We strongly believe our highly qualified nominees have the experience, skills and much needed independence to help Axcelis become the premier player in ion implantation. "
February 26, 2015
08:05 EDTACLSAxcelis wins new order for 'Purion XE' high enery implanter
Axcelis has received a new order for the company's Purion XE single wafer, high energy implanter. The Purion XE will support a new capacity expansion at a memory fab in the Asia Pacific Region, and will be used in high volume production of 3D NAND Flash devices. The system shipped in Q1.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use